Dr. Richard M. Glover II
Claim this profileAlliance for Multispecialty Research, LLC
Studies Obesity
Studies Cardiovascular Disease
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Richard M. Glover II is currently running
Retatrutide
for Obesity
The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/m\^2 or higher and Atherosclerotic Cardiovascular Disease and/or chronic kidney disease. The study will last for about 5 years. Participants will have up to 27 clinic visits with the study doctor.
Recruiting1 award Phase 32 criteria
Orforglipron
for Type 2 Diabetes and Obesity
This trial is testing a new diabetes medication called orforglipron to see if it is safer and more effective than insulin in people with type 2 diabetes who are overweight or obese and at higher risk for heart problems. The study will last several years and involve multiple visits.
Recruiting2 awards Phase 3
More about Richard M. Glover II
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Richard M. Glover II has experience with
- Insulin Glargine
- Orforglipron
- Retatrutide
Breakdown of trials Richard M. Glover II has run
Cardiovascular Disease
Chronic Kidney Disease
Type 2 Diabetes
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Richard M. Glover II specialize in?
Richard M. Glover II focuses on Obesity and Cardiovascular Disease. In particular, much of their work with Obesity has involved treating patients, or patients who are undergoing treatment.
Is Richard M. Glover II currently recruiting for clinical trials?
Yes, Richard M. Glover II is currently recruiting for 2 clinical trials in Newton Kansas. If you're interested in participating, you should apply.
Are there any treatments that Richard M. Glover II has studied deeply?
Yes, Richard M. Glover II has studied treatments such as Insulin Glargine, Orforglipron, Retatrutide.
What is the best way to schedule an appointment with Richard M. Glover II?
Apply for one of the trials that Richard M. Glover II is conducting.
What is the office address of Richard M. Glover II?
The office of Richard M. Glover II is located at: Alliance for Multispecialty Research, LLC, Newton, Kansas 67114 United States. This is the address for their practice at the Alliance for Multispecialty Research, LLC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.